CURCUMIN- A BOON FOR ORAL HEALTH

[1]  Gigliola Sica,et al.  Local Overexpression of V1a-Vasopressin Receptor Enhances Regeneration in Tumor Necrosis Factor-Induced Muscle Atrophy , 2014, BioMed research international.

[2]  Tao Zhang,et al.  Targeting cancer stem cells by curcumin and clinical applications. , 2014, Cancer letters.

[3]  K. Zandi,et al.  A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin , 2014, BioMed research international.

[4]  G. Zhai,et al.  Advances in clinical study of curcumin. , 2013, Current pharmaceutical design.

[5]  C. Mohanty,et al.  Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin , 2012, Expert opinion on drug delivery.

[6]  Chong Zhang,et al.  Food preservation effects of curcumin microcapsules , 2012 .

[7]  A. Verma,et al.  Characterization and Antimicrobial Activity of Nanocurcumin and Curcumin , 2011, 2011 International Conference on Nanoscience, Technology and Societal Implications.

[8]  Xia Zhao,et al.  Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. , 2011, Nanoscale.

[9]  Rupesh Kumar Basniwal,et al.  Curcumin nanoparticles: preparation, characterization, and antimicrobial study. , 2011, Journal of agricultural and food chemistry.

[10]  G. Bar-Sela,et al.  Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer , 2010, Nutrition and cancer.

[11]  B. Aggarwal,et al.  Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. , 2010, Biochemical pharmacology.

[12]  Zhaoxin Lu,et al.  Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. , 2009, International journal of food microbiology.

[13]  A. Maitra,et al.  Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. , 2009, Current drug discovery technologies.

[14]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[15]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[16]  R. H. Scofield,et al.  Improving the solubility and pharmacological efficacy of curcumin by heat treatment. , 2007, Assay and drug development technologies.

[17]  Daniel Normolle,et al.  Dose escalation of a curcuminoid formulation , 2006, BMC complementary and alternative medicine.

[18]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin , 2004, Clinical Cancer Research.

[19]  S. Jee,et al.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. , 2001, Anticancer research.

[20]  R. Kuttan,et al.  Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. , 1992, Indian journal of physiology and pharmacology.

[21]  R. Kuttan,et al.  Turmeric and Curcumin as Topical Agents in Cancer Therapy , 1987, Tumori.

[22]  R. Kuttan,et al.  Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.

[23]  Gurleen Kaur,et al.  Curcumin and its derivatives as chemotherapeutic agents , 2016 .

[24]  P. Bedi,et al.  Recent progress in biologically active xanthones , 2016 .

[25]  B. Aggarwal,et al.  Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.

[26]  K. Usmanghani,et al.  CURCUMA LONGA AND CURCUMIN: A REVIEW ARTICLE , 2010 .